|
Volume 272, Number 15,
Issue of April 11, 1997
pp. 9902-9906
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.
Regulation of Large Calcium-activated Potassium Channels by
Protein Phosphatase 2A*
(Received for publication, December 23, 1996, and in revised form, January 28, 1997)
Steven C.
Sansom
,
James D.
Stockand
§,
David
Hall
and
Bruce
Williams
From the Division of Renal Diseases and Hypertension and the
Department of Integrative Biology, Pharmacology, and Physiology, The
University of Texas Medical School, Houston, Texas 77073
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
Vasodilating agents induce relaxation of
mesangial cells, in part through cGMP-mediated activation of large
calcium-activated potassium channels (BKCa). Normally
quiescent in cell-attached patches, the response of BKCa to
nitric oxide, atrial natriuretic peptide, and dibutyryl cGMP
(Bt2cGMP) is characterized by a biphasic increase and then
decrease ("rundown") in open probability. Using the patch-clamp
method in conjunction with phosphatase inhibitors, we investigated
whether the run-down phase was the result of dephosphorylation by an
endogenous protein phosphatase. In cell-attached patches, cantharidic
acid (500 nM), okadaic acid (100 nM), and
calyculin A (100 nM), nondiscriminant inhibitors of protein
phosphatases 1 (PP1) and 2A (PP2A) at these concentrations, caused a
significantly greater and sustained response of BKCa to
Bt2cGMP. Within 2 min, the response of BKCa to
the combination of cantharidic acid and Bt2cGMP was greater
than the response to these agents added separately. Incubation of
mesangial cells with okadaic acid for 20 min at a concentration (5 nM) specific for PP2A increased the basal open probability
of BKCa and completely inhibited rundown after activation by Bt2cGMP. Incubation with calyculin A (10 nM), a more potent inhibitor of PP1, did not affect
BKCa activity. In inside-out patches, Bt2cGMP
plus MgATP caused a sustained activation of BKCa that was
inhibited by exogenous PP2A but not PP1. It is concluded that either
BKCa or a tightly associated regulator of BKCa
is a common substrate for endogenous cGMP-activated protein kinase, which activates BKCa, and PP2A, which inactivates
BKCa, in human mesangial cells.
INTRODUCTION
Mesangial cells, which are excitable and have contractile
properties similar to smooth muscle, regulate the glomerular filtration rate by modulating the capillary surface area (1-3). Recent
patch-clamp studies of human mesangial cells in culture have shown that
the mechanism and ion-selective channels involved in maintaining
contractile tone are similar or identical to those of vascular smooth
muscle (4, 5).
Large calcium-activated potassium channels
(BKCa),1 characterized in
mesangial cells (5, 6) and vascular smooth muscle (7), are not involved
in setting resting potential but respond in a negative feedback manner
to agonist-induced increases in contractile tone. Agonists such as
angiotensin II elevate intracellular calcium and depolarize the
membrane potential, producing an activation of BKCa. The
hyperpolarizing membrane potential inhibits further entry of cell
calcium by inactivating voltage-gated calcium channels. The gain in
this feedback mechanism is increased by smooth muscle relaxants such as
nitric oxide and atrial natriuretic peptide that, via cGMP-activated
kinase, lower the voltage and calcium thresholds for activating
BKCa (8, 9). However, activation of BKCa "on
cell" by vasorelaxants or Bt2cGMP is followed by an inactivation or run-down phase, in which BKCa returns to
base line 20 s after peak activity.
Substrate regulation by phosphorylation is a dynamic balance between
the forward kinase phosphorylation and the reverse dephosphorylation by
a protein phosphatase. Several studies have now shown that vasorelaxants activate BKCa through guanylyl cyclase and
cGMP-dependent protein kinase in both smooth muscle and
mesangial cells (9-11); however, the role of protein phosphatase has
been addressed only very recently (9, 12). Two such studies on tracheal
smooth muscle and neurohypophyseal cells supported the notion that cGMP stimulated BKCa by activating protein phosphatase 2A (12,
13), which activated BKCa by dephosphorylation. In
contrast, our laboratory previously showed that the mesangial
BKCa was activated by cGMP-activated protein kinase in the
presence of okadaic acid, an inhibitor of protein phosphatases 1 and 2A
(9, 13), suggesting that these phosphatases inactivated,
rather than activated, the mesangial BKCa.
The present studies were performed to elucidate the signaling pathways
involved in the run-down phase following activation of BKCa
by cGMP-dependent protein kinase. Using the cell-attached configuration and established phosphatase inhibitors, we specifically investigated the specific endogenous protein phosphatase involved in
regulating BKCa. Using inside-out patches, we then
determined the regulation of BKCa by protein phosphatases 1 and 2A.
EXPERIMENTAL PROCEDURES
Mesangial Cell Cultures
Human mesangial cells were isolated
originally by Abboud and co-workers (14) and cultured using standard
techniques. Mesangial cells were plated in Waymouth culture medium, pH
7.4, supplemented with 15 mM HEPES buffer, 2.0 mM glutamine, 0.66 unit/ml insulin, 1.0 mM
sodium pyruvate, 0.1 mM nonessential amino acids,
penicillin (100 units/ml), streptomycin (100 µg/ml), and fetal calf
serum (17% v/v). All experiments were performed using subpassages
6-10. During this generation span, mesangial cells maintained a
constant phenotype and typical smooth muscle-like spindle shape
(2).
Cells were subcultured onto individual 22 × 22 mm glass
coverslips (Fisher) and maintained for 1-2 days at 37 °C and 5%
CO2 in a humidified tissue culture incubator (Queue
Scimetrics Inc., Missouri City, TX). The subconfluent cells were
placed into an RC-24 perfusion chamber (Warner Instrument Corp.,
Hamden, CT) and perfused with a physiological salt solution (135 mM NaCl, 5 mM KCl, and 1.0 mM
CaCl2, pH 7.4).
Patch-Clamp Methods
Mesangial cells were prepared for
analysis of single BKCa channels using standard patch-clamp
techniques previously described (5, 15). Current recordings were made
after obtaining gigaohm seals with the patch electrode on the surface
of the cell (cell attached) or after withdrawing the patch (excised,
inside out). The unitary current (i), defined as zero for
the closed state, was determined as the mean of the best fit Gaussian
distribution of the amplitude histograms. Channels were considered in
an open state when the current was >(n 1/2)i and <(n + 1/2)i,
where n is the maximum number of current levels observed.
The probability of a channel existing in an open state
(Po) is defined as the time spent in the open
state divided by the total time of the recording. In all cases,
Vp implies the holding potential relative to the
pipette.
Experimental Design and Solutions
In all cell-attached
experiments, the pipette solution contained 140 mM KCl plus
10 mM HEPES buffer, pH 7.4, and the bath solution contained
135 mM NaCl, 5 mM KCl, 1 mM
CaCl2, and 10 mM HEPES, pH 7.4. The free
Ca2+ concentration of the bath, initially 1.0 mM, was adjusted to lower concentrations by buffering with
EGTA as described previously (16). In excised patches, the bathing
solution was replaced with 140 mM KCl, 1 µM
CaCl2, 10 mM HEPES, pH 7.4. Okadaic acid, cantharidic acid, and calyculin A, established inhibitors of PP1 and
PP2A, were used to establish the role of endogenous protein phosphatase
in regulation of BKCa. While monitoring BKCa
channels in cell-attached patches, these inhibitors were added to the
bathing solution in concentrations nonspecific for inhibition of PP1
and PP2A. The holding potential ( Vp) was either 80 mV or 0 mV, which resulted in outward and inward currents,
respectively. The effects of these inhibitors on the
cGMP-dependent activation of BKCa was
determined by adding inhibitor either in the continued presence of 10 µM dibutyryl cGMP (Bt2cGMP) or at least
30 s before the addition of Bt2cGMP. To determine if
the endogenous protein phosphatase was either 1 or 2A, cells were
incubated in either 5 nM okadaic acid (specific for PP2A)
or 10 nM calyculin A for 10-30 min before obtaining a
seal. Specific inhibition of BKCa by either exogenous PP2A
or PP1 was determined in inside-out patches with 140 mM KCl
in the bath and holding potentials of either 40 mV or 40 mV for
outward or inward currents, respectively. BKCa were
activated either by Bt2cGMP plus MgATP at a holding
potential of 40 mV or by Bt2cGMP plus MgATP plus
cGMP-activated protein kinase at a holding potential of 40 mV. PP2A
(0.5 unit/ml) or PP1 (1 unit/ml) was added in the continued presence of
Bt2cGMP plus MgATP with or without cGMP-activated protein
kinase. Groups were compared for statistical significance using the
paired t test or the ANOVA plus the Student-Newman-Keuls
test as appropriate. Cyclic GMP-activated kinase was purchased from
Promega. All other chemicals used in this study were purchased from
Sigma or Calbiochem.
RESULTS
Effects of Pharmacological Inhibitors of Protein Phosphatases on
Rundown of cGMP-activated BKCa
Experiments were
performed to determine if the run-down phase after adding
Bt2cGMP was the result of either PP1 or PP2A. Fig. 1A shows the effects of cantharidic acid (500 nM), a nonspecific inhibitor of PP1 and PP2A, on the
rundown of Bt2cGMP-activated BKCa in
cell-attached patches in the absence of a phosphatase inhibitor
(upper tracing) and with the simultaneous addition of cantharidic acid (lower tracing). The
Po of BKCa increased from <0.01 to
0.85 after 10 s with the addition of 10 µM
Bt2cGMP and then returned to base line in the next 90 s; after 2 min the Po was <0.01. However, when
Bt2cGMP and cantharidic acid were added together,
BKCa was activated to a Po that was
sustained at 0.78 after 2 min. Note that the channel amplitude
diminished after addition of cantharidic acid. A decrease in the
amplitude of BKCa is the result of a decrease in
electrochemical potential due to the combination of a decrease in the
intracellular potassium concentration and the hyperpolarization of the
membrane potential as BKCa is activated in the cell
membrane (8, 17).
Fig. 1.
Results of cell-attached experiments showing
the separate and additive effects of Bt2cGMP
(DB-cGMP) and cantharidic acid on the
Po of BKCa. The pipette
solutions contained 140 mM KCl, and the bathing solutions
were physiological salt solutions ( Vp = 80 mV).
Outward currents are positive. Arrows denote the closed
state. A, tracings showing the effects on BKCa when adding 10 µM Bt2cGMP (DB-cGMP,
upper tracing) and 10 µM Bt2cGMP plus
500 nM cantharidic acid (lower tracing) to the
bathing solution. The Po of BKCa was
increased by the addition of 10 µM Bt2cGMP from <0.01 to 0.85 after 10 s, after which it returned to base line during the next 90 s and fell to <0.01 after 2 min. The
combination of Bt2cGMP plus cantharidic acid activated
BKCa to a Po of 0.78 after 2 min.
Note a decrease in channel amplitude due to a decrease in
electrochemical driving force for BKCa. Distinct (inward)
currents are shown when command potential was changed to 0 mV.
B, tracings illustrating the effects on BKCa at
80 and 0 mV on the addition of cantharidic acid followed by cantharidic
acid plus Bt2cGMP to the bathing solution. In the
control, BKCa were quiescent at 0 mV, and the
Po was <0.001 at 80 mV. Approximately 60 s
after the addition of 500 nM cantharidic acid, the
Po increased to 0.084 and 0.005 at 80 and 0 mV,
respectively. In the continued presence of cantharidic acid, the
Po was further increased by Bt2cGMP
to a sustained value of 0.40 and 0.035 at 80 and 0 mV, respectively. C, bar graph summarizing the effects of
cantharidic acid on the run-down phase (120 s) after activation of
BKCa by Bt2cGMP ( Vp = 80 mV). Two minutes after the separate additions of 10 µM
Bt2cGMP and 500 nM cantharidic acid
(Canth) the open probabilities of BKCa were
0.011 ± 0.006 and 0.16 ± 0.05, respectively. Two minutes after the addition of Bt2cGMP plus cantharidic acid the
Po increased to 0.48 ± 0.10 (n = 5). *, p < 0.05 compared with the
values for Bt2cGMP and cantharidic acid.
[View Larger Version of this Image (16K GIF file)]
Fig. 1B shows current tracings of BKCa in a
cell-attached patch, illustrating the BKCa activity at a
Vp of 80 and 0 mV with cantharidic acid and
cantharidic acid plus Bt2cGMP. In the control,
BKCa were quiescent at 0 mV, and the
Po was <0.001 at 80 mV. Approximately 2 min
after the addition of 500 nM cantharidic acid, the
Po increased to 0.084 at 80 mV and 0.005 at 0 mV. Note the difference in open probability between 80 and 0 mV,
demonstrating the voltage dependence of BKCa. In the
continued presence of cantharidic acid, Bt2cGMP further
increased BKCa after 2 min to a sustained Po of 0.40 and 0.035 at 80 and 0 mV,
respectively. Thus, cantharidic acid eliminated the rundown in the
response of BKCa to Bt2cGMP. Moreover, the
effects of Bt2cGMP and phosphatase inhibitor were potentiating and independent of the holding potential.
A summary of the separate and combined effects on BKCa of
cantharidic acid and Bt2cGMP are shown in Fig.
1C. Two minutes after the separate additions of
Bt2cGMP and 500 nM cantharidic acid, the open
probability of BKCa was 0.011 ± 0.006 and 0.16 ± 0.05, respectively. Two minutes after the addition of
Bt2cGMP plus cantharidic acid, the
Po increased to a significantly higher value of
0.48 ± 0.10. This value was more than twice the value of the sum
of the separate additions, suggesting a potentiated effect of
Bt2cGMP and cantharidic acid.
Fig. 2 shows the effects of 100 nM okadaic
acid and 100 nM calyculin A on cGMP-activated
BKCa in cell-attached patches. At these concentrations, the
phosphatase inhibitors are nonspecific for PP2A and PP1 and are
effective within 120 s. As shown in Fig. 2A
( Vp = 0 mV), BKCa activated within
5 s from <0.001 to 0.10 in response to 10 µM
Bt2cGMP and then returned to base line after approximately
5 more seconds. In the continued presence of Bt2cGMP, the
addition of okadaic acid reactivated BKCa to a greater and
sustained value of 0.83 after 120 s. Similar results were obtained
with 100 nM calyculin A (Fig. 2B,
Vp = 80 mV). The Po of
BKCa increased from <0.001 to 0.42 within 5 s after
the addition of Bt2cGMP and then returned to base line within the next 20 s. However, after the addition of
Bt2cGMP plus 100 nM calyculin A, the
Po increased and remained at 0.65. The increase
in channel amplitude at 0 mV and the reduction in amplitude at 80 mV
shows that the membrane potential is hyperpolarizing, as
BKCa is activated by either okadaic acid or calyculin
A.
Fig. 2.
Effects of 100 nM okadaic acid
and 100 nM calyculin A on Bt2cGMP-activated
BKCa in cell-attached patches. A (0 mV), BKCa was activated within 5 s from <0.001 to 0.10 in
response to 10 µM Bt2cGMP
(DB-cGMP) and then returned to base line after approximately
5 more seconds. In the continued presence of Bt2cGMP, the
addition of okadaic acid reactivated BKCa to a greater and sustained value of 0.83 after 120 s. Similar results were obtained with 100 nM calyculin A (B, 80 mV). The
Po of BKCa increased from <0.001 to
0.42 within 5 s after the addition of Bt2cGMP and
returned to base line within the next 20 s. However, after the
addition of Bt2cGMP plus 100 nM calyculin A,
the Po increased and remained at 0.65. The
increase in channel amplitude at 0 mV and the reduction in amplitude at
80 mV shows that the membrane potential is hyperpolarizing as
BKCa is activated by either okadaic acid or calyculin A. All other conditions are the same as in Fig. 1.
[View Larger Version of this Image (13K GIF file)]
Pharmacological Differentiation between Endogenous PP1 and
PP2A
Low concentrations of okadaic acid (5 nM) and
calyculin A (10 nM) were used to determine if the
endogenous phosphatase was PP1 or PP2A. Although IC50
values for phosphatase inhibition for okadaic acid and calyculin A are
dependent on the substrate and purity of inhibitor, in general okadaic
acid is at least 30-fold more potent for PP2A than PP1 (18, 19), and
calyculin A is 30-fold more potent than okadaic acid for inhibiting PP1
(19, 20). Therefore, if PP1 were the endogenous phosphatase, it would be expected that BKCa would be activated by calyculin A
more than okadaic acid. If PP2A were the endogenous phosphatase, it
would be expected that BKCa would be activated more by
okadaic acid than calyculin A.
In the experiments of Fig. 3, okadaic acid (5 nM) and calyculin A (10 nM) were added to the
bathing medium 20-50 min before obtaining a cell-attached patch. As
shown by the upper current tracing of Fig. 3A, in
the presence of okadaic acid, BKCa was active
(Po = 0.063) after obtaining the seal at 80 mV.
The addition of Bt2cGMP increased the
Po further to a sustained value of 0.32. As
shown in Fig. 3B, BKCa was relatively quiescent
(Po < 0.005) after the addition of calyculin A
and was activated transiently to 0.227 on the addition of
Bt2cGMP. This rundown to base line approximately 20 s
after peak activation was similar to control experiments (see Fig.
1A). These results are summarized in Fig. 3B. In
control cells, the Po of BKCa was
increased by Bt2cGMP to a value of 0.19 ± 0.04 after
5 s and ran down to base line after 120 s (n = 6). After incubation with okadaic acid, the basal Po was 0.18 ± 0.07 and increased to
0.29 ± 0.05 and 0.25 ± 0.05 after 5 and 120 s,
respectively (n = 4). After incubation with calyculin A
(n = 4), the Po increased from a
basal of 0.002 ± 0.001 to 0.20 ± 0.05 after 5 s and
returned near the base line value (0.008 ± 0.006) after 120 s. Using the ANOVA plus the Student-Newman-Keuls test, the effects of
okadaic acid at basal and Bt2cGMP (120 s) were
significantly greater than the respective Po
values for control and calyculin A. These results indicate that
BKCa are maintained quiescent in cell-attached patches by
endogenous PP2A. Moreover, specific inhibition of PP2A (by 5 nM okadaic acid) prevents the rundown after activation of
BKCa by Bt2cGMP in cell-attached patches.
Fig. 3.
Results of cell-attached experiments showing
typical tracings (A) and a summary (B) of the
activation of BKCa by Bt2cGMP after incubating
cells for 20-50 min with 5 nM okadaic acid and 10 nM calyculin A. The holding potential
( Vp) was 80 mV. A, in the upper
tracing, the Po of BKCa was
0.063 on obtaining a seal with cells incubated in okadaic acid. The
subsequent addition of 10 µM Bt2cGMP
(DB-cGMP) increased the Po to a
sustained value of 0.32. In the lower tracing, the basal
Po of BKCa from cells incubated in
calyculin A was <0.005. After adding Bt2cGMP,
Po increased transiently to 0.217 and then
returned to 0.024 after 20 s. B, summary of the
activation pattern of BKCa after the addition of
Bt2cGMP (10 µM) in the control and
in the presence of okadaic acid (5 nM) and calyculin A (10 nM) for 20 to 50 min ( Vp = 80 mV). The
blank bars represent the basal Po,
and the cross-hatched and solid bars represent
the Po between 5 and 15 s and between 120 and 140 s, respectively, after the addition of
Bt2cGMP. In the control cells, the
Po was increased by Bt2cGMP to a
value of 0.19 ± 0.04 after 5 s and then ran down to base
line after 120 s (n = 6). In the presence of 5 nM okadaic acid, the basal Po was
0.18 ± 0.07 (n = 4) and increased to 0.29 ± 0.05 and 0.25 ± 0.05 after 5 s and 120 s, respectively.
After incubation with calyculin A, the Po
(n = 4) increased from 0.002 ± 0.001 to 0.20 ± 0.05 after 5 s and returned near the base line value
(0.008 ± 0.006) after 120 s. The asterisks denote
significant (p < 0.05) increases in basal and
Bt2cGMP (120 s) when compared with the control and
calyculin A groups using the ANOVA plus the Student-Newmann-Keuls test.
[View Larger Version of this Image (36K GIF file)]
Effects of Exogenous PP2A and PP1
The inside-out patch
configuration was used to determine the effects of exogenous PP2A and
PP1 on BKCa. Fig. 4 shows the inactivation of cGMP-activated BKCa by PP2A. As shown in the continuous
tracing of Fig. 4A, dibutyryl cyclic GMP plus MgATP
activated BKCa from 0.029 to 0.332, and the subsequent
addition of PP2A inactivated BKCa to 0.098. However, there
was no effect of PP1 on cGMP-activated BKCa (not shown).
These data are summarized in the bar graph of Fig.
4B. In each experiment, after activation of BKCa
by Bt2cGMP plus MgATP in either the absence or presence of
cGMP-activated protein kinase, PP2A (n = 5) decreased
the Po from 0.57 ± 0.11 to 0.40 ± 0.14 (p < 0.025, paired t test). However,
the Po was 0.66 ± 0.11 and 0.70 ± 0.13 (n = 3; not significant) before and after the
addition of PP1.
Fig. 4.
Effects of protein phosphatases on
Bt2cGMP-activated BKCa in inside-out
patches. The holding potential ( Vp) was 40 mV. The pipette and bathing solutions contained symmetrical 140 mM KCl. A, the continuous tracing
shows the activating response from 0.029 in the control to 0.332 with
10 µM Bt2cGMP (DB-cGMP) plus 0.1 mM MgATP (top). The lower tracing
shows the subsequent inactivation to 0.098 by 0.5 unit/ml PP2A.
B, summary of the effects of PP2A and PP1 (1 unit/ml) on
Bt2cGMP-activated BKCa. PP2A significantly (p < 0.025, n = 5) decreased the
Po of BKCa from 0.57 ± 0.11 to 0.40 ± 0.14. The Po of BKCa
before and after the addition of PP1 was 0.66 ± 0.11 and
0.70 ± 0.13, respectively (not significant, n = 3).
[View Larger Version of this Image (36K GIF file)]
DISCUSSION
This study further defined the signal transduction pathways for
regulating BKCa channels in a contractile cell. Three
phosphatase inhibitors, in concentrations that inhibit both PP1 and
PP2A, caused a larger and more sustained increase in open probability of BKCa in response to Bt2cGMP, the second
messenger mediator for relaxation by nitric oxide and atrial
natriuretic peptide. Basal open probability of BKCa was
increased by okadaic acid in concentrations specific for PP2A but not
by calyculin A, a more potent inhibitor of PP1, indicating that
endogenous PP2A but not PP1 was maintaining BKCa in a
dephosphorylated quiescent state. It was shown that exogenous PP2A, but
not PP1, applied to the cytosolic side of BKCa in
inside-out patches can specifically inhibit the activation of
BKCa by cGMP-dependent protein kinase.
Biphasic Response of BKCa to cGMP
In both smooth
muscle and mesangial cells, BKCa are activated by
cGMP-dependent protein kinase (7, 9). However, after activation by Bt2cGMP in cell-attached patches, the open
probability of the mesangial BKCa rapidly runs down to
base-line levels. The present study shows that the run-down phase is
due to the presence of PP2A, which would dephosphorylate
BKCa. Phosphatase-induced channel rundown has been more
commonly described for channels in excised patches. Kubokawa et
al. (21) found that renal Kd(ATP) channels run down in excised patches due primarily to the presence of
PP2A. However, phosphatase-induced rundown is not only found in excised
patches; it was also shown that okadaic acid prevents rundown of
Ba2+ current (whole cell) in dissociated helix neurons
(22).
It is not understood why the effects of cGMP-dependent
kinase are transient and ultimately overcome by a phosphatase that presumably dephosphorylates and inactivates BKCa despite
the continued presence of Bt2cGMP. However, several
mechanisms could be involved in the temporary inhibition and then
activation of a protein phosphatase to initiate the run-down phase. A
similar type of biphasic activation was demonstrated for
Ca2+/calmodulin-dependent protein kinase II,
also a substrate for PP2A (23). An increase in intracellular
Ca2+ in the rat brain is accompanied by a sequential
autophosphorylated increase and then decrease in phosphorylation
level of Ca2+/calmodulin-dependent protein
kinase II. The decrease in phosphorylation was blocked by 1 nM okadaic acid. It was suggested by these authors that an
increase in intracellular calcium autophosphorylated a serine/threonine
protein kinase (described by Guo et al. (24)) that would
temporarily phosphorylate and inhibit PP2A. In time, PP2A would
autodephosphorylate and inactivate
Ca2+/calmodulin-dependent protein kinase II. A
similar mechanism may be involved whereby cGMP temporarily activates an
inhibitor of PP2A. Although a recent study described inhibition of PP1
by cGMP-dependent protein kinase (25), a cGMP-activated
inhibitor of PP2A has not been described.
Regulation of BKCa by Phosphatases
Although
several studies have described regulation of ion-selective channels by
cAMP- and cGMP-dependent protein kinases, the reversal of
channel phosphorylation by phosphoprotein phosphatases has been
investigated only recently (26-31). The present study is one of a few
that have now implicated PP2A as a physiological regulator of
BKCa channels (12, 13, 32). However, for cGMP-activated protein kinase-activated BKCa, at least two previous
studies using three different cell types (12, 13) have shown either
that PP2A activates BKCa or cGMP-activated protein kinase
does not activate BKCa in the presence of inhibitors of
PP2A. These results contrast with our study which showed that
BKCa was inactivated by PP2A and activated by either
cGMP-activated protein kinase or inhibitors of PP2A.
Our disparate results may be explained by another study by
Reinhart et al. (32) who have shown that BKCa
from the brain expresses two types of channels in planar bilayers with
respect to PP2A regulation. Type 1 channels are activated by
cAMP-activated protein kinase and inactivated by PP2A. Type 2 BKCa channels are inactivated by cAMP-activated protein
kinase and activated by PP2A. Although this was a protein kinase A and
not a cGMP-activated protein kinase-activated mechanism, it is possible
that there are two types of BKCa with respect to regulation
of phosphorylation and dephosphorylation by cGMP-activated kinase.
However, these type 2 BKCa channels have not been observed
in mesangial cells.2 When the properties of
the PP2A-activated (type 2) channels in tracheal smooth muscle (12) are
compared with the mesangial BKCa of this study, we find
that the reported single channel conductance (in symmetrical 140 mM KCl) of the tracheal BKCa (257 ± 13 picosiemens) is somewhat larger than the mesangial BKCa
(206 ± 18 picosiemens, see Ref. 5). However, voltage-gated
activation response in 1 µM Ca2+ is similar
(see Refs. 5 and 12). It remains to be determined if these are distinct
isoforms of BKCa.
The dominant type of BKCa in smooth muscle could be
determined by the contractile response to low concentrations of okadaic acid. Since PP1 dephosphorylates myosin light chain kinase (33), higher
concentrations of okadaic acid would be expected to induce contractions. If type 1 channels predominate, it would be expected that
okadaic acid in concentrations of 1-10 nM would inhibit
smooth muscle contraction. That range of concentrations of okadaic acid would induce smooth muscle contraction if type 2 channels predominate. In support of type 1 channels, at least two studies have shown that low
concentrations of okadaic acid relax vascular smooth muscle (34, 35).
Although the kinase specific for activation of the mesangial
BKCa appears identical to smooth muscle, the effects of
okadaic acid on mesangial contraction have not been determined.
It would not be surprising if BKCa is regulated by
different mechanisms in different cell types. Tseng-Crank et al.
(36) found that HSLO, the human gene encoding the
calcium-activated potassium channel, contains multiple splice variants
in the brain. It was recently found that the mesangial BKCa
contains at least two of these variants of HSLO (37). It is
therefore feasible that the differential expression of these vari-ants
would confer different sites for regulation by kinases and
phosphatases.
In summary, we have demonstrated that the mesangial BKCa is
not regulated by an all-or-none phosphorylation or dephosphorylation mechanism but rather by a dynamic enzymatic balance between
cGMP-activated protein kinase and protein phosphatase 2A, which
specifically activate and inactivate BKCa, respectively. It
remains to be established, however, if there are multiple molecular
variants of BKCa that are differentially modulated by
kinase/phosphatase signal transduction mechanisms.
FOOTNOTES
*
This work was supported by American Diabetes Association
Award 89 (to S. C. S).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Medicine,
Division of Renal Diseases and Hypertension, University of Texas
Medical School, 6431 Fannin St., Houston, TX 77030. Tel.: 713-792-5425;
Fax: 713-794-1197.
§
This work was done in partial fulfillment for the Ph.D. degree.
Present address: Dept. of Physiology, Emory University School of
Medicine, 1648 Pierce Dr., Atlanta, GA 30322.
1
The abbreviations used are: BKCa,
large calcium-activated potassium channels; Bt2cGMP,
dibutyryl cGMP; PP1, protein phosphatase 1; PP2A, protein phosphatase
2A; ANOVA, analysis of variance.
2
In mesangial cells, we do not observe channels
similar to type 2 BKCa (activated by PP2A). All channels
that are activated by Bt2cGMP are also inactivated by PP2A
or activated by inhibitors of PP2A. One difference in our experimental
conditions was that we preactivated BKCa with
Bt2cGMP before adding PP2A. We subsequently attempted to
mimic the experimental conditions described by Zhou et al.
(12), who did not preactivate BKCa with cGMP. We found that
PP2A (0.5 unit/ml) inactivated the Po of
BKCa by 71 ± 10% (n = 2). Therefore,
the type 2 BKCa channel may be differentially expressed in
tracheal smooth muscle and mesangial cells.
ACKNOWLEDGEMENTS
The human mesangial cells were a generous
gift from Hanna Abboud of the University of Texas, San Antonio. We
thank Dr. Shirish Shenolikar for the advice regarding the use and
specificity of protein phosphatase inhibitors.
REFERENCES
-
Haddad, G. E., Sperelakis, N., and Bkaily, G.
(1995)
Mol. Cell. Biochem.
148,
89-94
[CrossRef][Medline]
[Order article via Infotrieve]
-
Mene, P., Simonson, M. S., and Dunn, M. J.
(1989)
Physiol. Rev.
69,
1347-1424
[Free Full Text]
-
Schlondorff, D.
(1987)
FASEB J.
1,
272-281
[Abstract]
-
Ling, B. N., Seal, E. E., and Eaton, D. C.
(1993)
J. Clin. Invest.
92,
2141-2151
-
Stockand, J. D., and Sansom, S. C.
(1994)
Am. J. Physiol.
267,
C1080-C1086
[Abstract/Free Full Text]
-
Sansom, S. C., and Stockand, J. D.
(1996)
Clin. Exp. Pharmacol. Physiol.
23,
76-82
[Medline]
[Order article via Infotrieve]
-
Brayden, J. E., and Nelson, M. T.
(1992)
Science
256,
532-535
[Abstract/Free Full Text]
-
Stockand, J. D., and Sansom, S. C.
(1996)
Am. J. Physiol.
270,
C1773-C1779
[Abstract/Free Full Text]
-
Stockand, J. D., and Sansom, S. C.
(1996)
Am. J. Physiol.
271,
C1669-C1677
[Abstract/Free Full Text]
-
Robertson, B. E., Schubert, R., Hescheler, J., and Nelson, M. T.
(1993)
Am. J. Physiol.
265,
C299-C303
[Abstract/Free Full Text]
-
Archer, S. L., Huang, J. M. C., Hampl, V., Nelson, D. P., Shultz, P. J., and Weir, E. K.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
7583-7587
[Abstract/Free Full Text]
-
Zhou, X. B., Ruth, P., Schlossmann, J., Hofmann, F., and Korth, M.
(1996)
J. Biol. Chem.
271,
19760-19767
[Abstract/Free Full Text]
-
White, R. E., Lee, A. B., Shcherbatco, A. D., Lincoln, T. M., Schonbruan, A., and Armstrong, D. L.
(1993)
Nature
361,
263-266
[CrossRef][Medline]
[Order article via Infotrieve]
-
Jaffer, F., Saunders, C., Shultz, P., Throckmorton, D., Weinshell, E., and Abboud, H. E.
(1989)
Am. J. Pathol.
135,
261-269
[Abstract]
-
Hamill, O. P., Marty, A., Neher, E., Sackmann, B., and Sigworth, F. J.
(1981)
Pfluegers Arch. Eur. J. Physiol
391,
85-100
-
Fabiato, A., and Fabiato, F.
(1979)
J. Physiol. (Londo.)
75,
463-505
-
Ganz, M. B., Kasner, S. E., and Unwin, R. J.
(1995)
Am. J. Physiol.
37,
F1081-F1086
-
Suganuma, M., Fujiki, H., Okabe, S., Nishiwaki, S., Brautigan, D., Ingebritsen, T. S., and Rosner, M. R.
(1992)
Toxicon
30,
873-878
[Medline]
[Order article via Infotrieve]
-
Ishihara, H., Martin, B. L., Brautigan, D. L., Karaki, H., Ozaki, H., Kato, Y., Fusetani, N., Watabe, S., Hashimoto, K., Uemura, D., and Hartshorme, P. J.
(1989)
Biochem. Biophys. Res. Commun.
159,
871-877
[CrossRef][Medline]
[Order article via Infotrieve]
-
Pugazhenthi, S., Yu, B., Gali, R. R., and Khandelwal, R. L.
(1993)
Biochim. Biophys. Acta
1179,
271-276
[Medline]
[Order article via Infotrieve]
-
Kubokawa, M., McNicholas, C. M., Higgins, M. A., Wang, W. H., and Giebisch, G.
(1995)
Am. J. Physiol.
269,
F355-F362
[Abstract/Free Full Text]
-
Yakel, J.
(1992)
Pfluegers Arch. Eur. J. Physiol.
420,
470-478
[CrossRef]
-
Barnes, G. N., Slevin, J. T., and Vanaman, T. C.
(1995)
J. Neurochem.
64,
340-353
[Medline]
[Order article via Infotrieve]
-
Guo, H., Reddy, S. A. G., and Damuni, Z.
(1993)
J. Biol. Chem.
268,
11193-11198
[Abstract/Free Full Text]
-
Tokui, T., Brozovich, F., Ando, S., and Ikebe, M.
(1996)
Biochem. Biophys. Res. Commun.
220,
777-783
[CrossRef][Medline]
[Order article via Infotrieve]
-
McNicholas, C. M., Wang, W., Ho, K., Hebert, S. C., and Giebisch, G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
8077-8081
[Abstract/Free Full Text]
-
Reinhart, P. H., and Levitan, I. B.
(1995)
J. Neurosci.
15,
4572-4579
[Abstract]
-
Lee, M.-Y., Bang, H.-W., Lim, I.-J., Uhm, D.-Y., and Rhee, S.-D.
(1994)
Pfluegers Arch. Eur. J. Physiol.
429,
150-152
-
La, B.-Q., Carosi, S. L., Valentich, J., Shenolikar, S., and Sansom, S. C.
(1991)
Am. J. Physiol.
260,
C1217-C1223
[Abstract/Free Full Text]
-
Reinhart, P. H., Chung, S., and Levitan, I. B.
(1989)
Neuron
2,
1031-1041
[CrossRef][Medline]
[Order article via Infotrieve]
-
Groschner, K., Schuhmann, K., Mieskes, G., Baumgartner, W., and Romanin, C.
(1996)
Biochem. J.
318,
513-517
-
Reinhart, P. H., Chung, S., Martin, B. L., Brautigan, D. L., and Levitan, I. B.
(1991)
J. Neurosci.
11,
1627-1635
[Abstract]
-
Mitsui, T., Inagaki, M., and Ikebe, M.
(1992)
J. Biol. Chem.
267,
16727-16735
[Abstract/Free Full Text]
-
Ashizawa, N., Kobayashi, F., Tanaka, Y., and Nakayama, K.
(1989)
Biochem. Biophys. Res. Commun.
162,
971
[CrossRef][Medline]
[Order article via Infotrieve]
-
Karaki, H., Mitsui, H., Nagase, H., Ozaki, S., Shibata, S., and Uemura, D.
(1989)
Br. J. Pharmacol.
98,
590
[Medline]
[Order article via Infotrieve]
-
Tseng-Crank, J., Foster, C. D., Kraase, J. D., Mertz, R., Godinot, N., DiChiara, T. J., and Reinhart, P. H.
(1994)
Neuron
13,
1315-1330
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sansom, S. C., Lopreato, G., Stockand, J., and Atkinson, N.
(1995)
J. Am. Soc. Nephrol.
6,
3
(abstr.)
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. L. Pluznick and S. C. Sansom
BK channels in the kidney: role in K+ secretion and localization of molecular components
Am J Physiol Renal Physiol,
September 1, 2006;
291(3):
F517 - F529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ma, J. L. Pluznick, and S. C. Sansom
Ion Channels in Mesangial Cells: Function, Malfunction, or Fiction
Physiology,
April 1, 2005;
20(2):
102 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-H. Lim and C.-S. Park
Identification and Functional Characterization of Ankyrin-Repeat Family Protein ANKRA as a Protein Interacting with BKCa Channel
Mol. Biol. Cell,
March 1, 2005;
16(3):
1013 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Hebert, G. Desir, G. Giebisch, and W. Wang
Molecular Diversity and Regulation of Renal Potassium Channels
Physiol Rev,
January 1, 2005;
85(1):
319 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. E. Kudlacek, J. L. Pluznick, R. Ma, B. Padanilam, and S. C. Sansom
Role of h{beta}1 in activation of human mesangial BK channels by cGMP kinase
Am J Physiol Renal Physiol,
August 1, 2003;
285(2):
F289 - F294.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. L. Faber and P. Sah
Calcium-Activated Potassium Channels: Multiple Contributions to Neuronal Function
Neuroscientist,
June 1, 2003;
9(3):
181 - 194.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Janssens, J. Jordens, I. Stevens, C. Van Hoof, E. Martens, H. De Smedt, Y. Engelborghs, E. Waelkens, and J. Goris
Identification and Functional Analysis of Two Ca2+-binding EF-hand Motifs in the B"/PR72 Subunit of Protein Phosphatase 2A
J. Biol. Chem.,
March 14, 2003;
278(12):
10697 - 10706.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, N. S. Magoski, and L. K. Kaczmarek
Prolonged Activation of Ca2+-Activated K+ Current Contributes to the Long-Lasting Refractory Period of Aplysia Bag Cell Neurons
J. Neurosci.,
December 1, 2002;
22(23):
10134 - 10141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. MA and S. C. SANSOM
Epidermal Growth Factor Activates Store-Operated Calcium Channels in Human Glomerular Mesangial Cells
J. Am. Soc. Nephrol.,
January 1, 2001;
12(1):
47 - 53.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. C. Sansom, R. Ma, P. K. Carmines, and D. A. Hall
Regulation of Ca2+-activated K+ channels by multifunctional Ca2+/calmodulin-dependent protein kinase
Am J Physiol Renal Physiol,
August 1, 2000;
279(2):
F283 - F288.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Brenner, T. J. Jegla, A. Wickenden, Y. Liu, and R. W. Aldrich
Cloning and Functional Characterization of Novel Large Conductance Calcium-activated Potassium Channel beta Subunits, hKCNMB3 and hKCNMB4
J. Biol. Chem.,
February 25, 2000;
275(9):
6453 - 6461.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Herzig and J. Neumann
Effects of Serine/Threonine Protein Phosphatases on Ion Channels in Excitable Membranes
Physiol Rev,
January 1, 2000;
80(1):
173 - 210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Alioua, Y. Tanaka, M. Wallner, F. Hofmann, P. Ruth, P. Meera, and L. Toro
The Large Conductance, Voltage-dependent, and Calcium-sensitive K+ Channel, Hslo, Is a Target of cGMP-dependent Protein Kinase Phosphorylation in Vivo
J. Biol. Chem.,
December 4, 1998;
273(49):
32950 - 32956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. STOCKAND and S. C. SANSOM
Glomerular Mesangial Cells: Electrophysiology and Regulation of Contraction
Physiol Rev,
July 1, 1998;
78(3):
723 - 744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tian, H.-G. Knaus, and M. J. Shipston
Glucocorticoid Regulation of Calcium-activated Potassium Channels Mediated by Serine/Threonine Protein Phosphatase
J. Biol. Chem.,
May 29, 1998;
273(22):
13531 - 13536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Stockand, M. Silverman, D. Hall, T. Derr, B. Kubacak, and S. C. Sansom
Arachidonic acid potentiates the feedback response of mesangial BKCa channels to angiotensin II
Am J Physiol Renal Physiol,
April 1, 1998;
274(4):
F658 - F664.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|